We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Simple Single-Drop Test for Vitamin B12 Deficiency Developed

By LabMedica International staff writers
Posted on 04 Nov 2014
Researchers have developed a novel method, requiring only a single drop of blood, to test for vitamin B12 deficiency that is sensitive enough to work on anyone, including newborn babies.

Vitamin B12 deficiency can now be tested with a single drop of blood collected from a finger prick, and then simply blotted and dried overnight on a test card consisting of filter paper. More...
Researchers from University of British Columbia (UBC; Vancouver, BC, Canada) led by Prof. Yvonne Lamers, developed the dried blood spot card analysis to be sensitive enough to measure the amount of methylmalonic acid (MMA), indicator of B12 level. “This minimally invasive approach helps us measure deficiency in an easier and more convenient way, especially in large samples of people,” says Prof. Lamers, “Our method is the first to make dried blood spot analysis sensitive enough to test healthy people for B12 deficiency.”

The new method has the potential to be added to BC's Newborn Screening Program, which tests for treatable disorders in all infants born in BC. B12 deficiency, if not detected and treated early, can cause delayed brain development, slow learning, and digestion problems. Treatment includes injections, supplements, or dietary change. “We are interested in Dr. Lamers’ method, which may be sensitive enough to detect and confirm B12 deficiency using the blood spot cards currently collected on BC newborns,” says Hilary Vallance, director of the BC Newborn Screening Program. Roughly 5% of Canadian adults are B12 deficient and 20% show marginal sufficiency, according to Statistics Canada. In developing countries, deficiency is as high as 50% to 80% of the population.

The method also simplifies blood sample collection and testing in rural or remote areas where sophisticated lab equipment is unavailable. It is currently being used in a research project in rural Indonesia.

The study, published by Schroder TH et al. in the October 1, 2014 issue of the Journal of Nutrition, involved testing the new method on 94 healthy young women in Vancouver.

Related Links:

University of British Columbia 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.